ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd (ENLV)

1.145
-0.035
(-2.97%)
Closed 12 January 8:00AM
1.145
0.00
(0.00%)
After Hours: 8:56AM
Advanced chart

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.145
Bid
1.10
Offer
1.23
Volume
78,562
1.12 Day's Range 1.21
0.8101 52 Week Range 4.59
Market Cap
Previous Close
1.18
Open
1.18
Last Trade
3
@
1.14
Last Trade Time
Financial Volume
US$ 90,862
VWAP
1.1566
Average Volume (3m)
254,937
Shares Outstanding
20,880,000
Dividend Yield
-
PE Ratio
-0.82
Earnings Per Share (EPS)
-1.39
Revenue
-
Net Profit
-29.07M

About Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Ness Ziona, Center, Isr
Founded
-
Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was US$1.18. Over the last year, Enlivex Therapeutics shares have traded in a share price range of US$ 0.8101 to US$ 4.59.

Enlivex Therapeutics currently has 20,880,000 shares in issue. The market capitalisation of Enlivex Therapeutics is US$24.64 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.82.

ENLV Latest News

Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Ness-Ziona, Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Enlivex Adopts Bitcoin Treasury Reserve Strategy

Nes-Ziona, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis

Nes-Ziona, Israel, Nov. 14, 2024 (GLOBE NEWSWIRE) --  Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.075-6.147540983611.221.271.1451175701.2293092CS
4-0.0852-6.92570313771.23021.271.121244281.20462212CS
12-0.535-31.84523809521.681.710.81012549371.25134191CS
26-0.205-15.18518518521.351.750.81011541491.31607216CS
52-2.135-65.09146341463.284.590.81011394061.7299262CS
156-4.755-80.5932203395.98.640.8101764622.65820139CS
260-7.455-86.68604651168.629.40.81011766288.89646998CS

ENLV - Frequently Asked Questions (FAQ)

What is the current Enlivex Therapeutics share price?
The current share price of Enlivex Therapeutics is US$ 1.145
How many Enlivex Therapeutics shares are in issue?
Enlivex Therapeutics has 20,880,000 shares in issue
What is the market cap of Enlivex Therapeutics?
The market capitalisation of Enlivex Therapeutics is USD 24.64M
What is the 1 year trading range for Enlivex Therapeutics share price?
Enlivex Therapeutics has traded in the range of US$ 0.8101 to US$ 4.59 during the past year
What is the PE ratio of Enlivex Therapeutics?
The price to earnings ratio of Enlivex Therapeutics is -0.82
What is the reporting currency for Enlivex Therapeutics?
Enlivex Therapeutics reports financial results in USD
What is the latest annual profit for Enlivex Therapeutics?
The latest annual profit of Enlivex Therapeutics is USD -29.07M
What is the registered address of Enlivex Therapeutics?
The registered address for Enlivex Therapeutics is 14 EINSTEIN STREET, NESS ZIONA, CENTER, 7403618
What is the Enlivex Therapeutics website address?
The website address for Enlivex Therapeutics is www.enlivex.com
Which industry sector does Enlivex Therapeutics operate in?
Enlivex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.69M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.83M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.31M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
203.27M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
175.21M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
174.99M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M

ENLV Financials

Financials

ENLV Discussion

View Posts
redspinelpinktopaz redspinelpinktopaz 1 month ago
They're advertising on CNBC. What's that all about?
👍️0
glenn1919 glenn1919 1 month ago
enlv...................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 months ago
ENLV.........................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 months ago
ENLV under $4
👍️0
TrendTrade2016 TrendTrade2016 10 months ago
ENLV...NEXT BIO BEAST READY TO break out
👍️0
MOCKBA MOCKBA 6 years ago
I see ok, they should send a PR about it!
👍️0
dinogreeves dinogreeves 6 years ago
I mean that ENLV is now Nasdaq compliant, there are no issues with Nasdaq on their filings,
👍️0
MOCKBA MOCKBA 6 years ago
What you mean by that?
👍️0
dinogreeves dinogreeves 6 years ago
ENLV Nasdaq compliant now, should get a press release soon.
👍️0
dinogreeves dinogreeves 6 years ago
checkout website you'll be impressed

https://www.enlivex.com
👍️0
MOCKBA MOCKBA 6 years ago
Dino, grabbed a small position, looks very intriguing to say the least
👍️0
dinogreeves dinogreeves 6 years ago
They have over 35 million in cash man, no dilution for at least 2 years. Buy ENLV with everything you got.
👍️0
dinogreeves dinogreeves 6 years ago
This is ENLV now, buy all you can, they reverse merged with ORPN
👍️0
dinogreeves dinogreeves 6 years ago
This is one the best bios out there, soon to surpass what BPTH did
👍️0
whytestocks whytestocks 6 years ago
News: $ORPN Bioblast Announces Effectiveness of Eight to One Reverse Split

Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...

Find out more https://marketwirenews.com/news-releases/bioblast-announces-effectiveness-of-eight-to-one-reverse-split-7810132.html
👍️0
ClayTrader ClayTrader 6 years ago
* * $ORPN Video Chart 02-19-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 6 years ago
* * $ORPN Video Chart 11-20-18 * *

Link to Video - click here to watch the technical chart video

👍️0
r1aviator r1aviator 6 years ago
$ORPN

Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors

https://twitter.com/birdseyepix/status/1064655592529117184?s=21
👍️0
r1aviator r1aviator 6 years ago
Running :)

$ORPN
👍️0
r1aviator r1aviator 6 years ago
Took a starter

$ORPN
👍️0
ClayTrader ClayTrader 7 years ago
* * $AXXA Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 7 years ago
* * $SDRL Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 7 years ago
* * $ORPN Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
europtiger europtiger 7 years ago
Crazy downer but buying more 3,10 as i belive Shorts will bien there Fingers
👍️0
europtiger europtiger 7 years ago
Looking good

Nice bids coming in

👍️0
crudeoil24 crudeoil24 7 years ago
Very nice call! Blast off > Blast Pharma! orpn
👍️0
europtiger europtiger 7 years ago
Here we Go
👍️0
europtiger europtiger 7 years ago
Yep float has been traded allready

Hope for breakout just bought more

But stop is in
👍️0
crudeoil24 crudeoil24 7 years ago
Traders running this low floater > Brooklyn!
👍️0
europtiger europtiger 7 years ago
Got 2,90‘s
👍️0
Golden Cross Golden Cross 7 years ago
ORPN cheat sheet:

https://www.barchart.com/stocks/quotes/ORPN/cheat-sheet
👍️0
Golden Cross Golden Cross 7 years ago
Short squeeze info:


http://shortsqueeze.com/?symbol=orpn&submit=Short+Quote%E2%84%A2
👍️0
Golden Cross Golden Cross 7 years ago
MACD looking bullish
👍️0
Golden Cross Golden Cross 7 years ago
Chart shaping up:

👍️0
DewDiligence DewDiligence 7 years ago
Caveat emptor! This looks like a financing deal is coming soon.
👍️0
europtiger europtiger 7 years ago
Running hard

Super Low Float
👍️0
Me stocks Me stocks 7 years ago
This one is investment. It will go to 15$ at least in 2018.
👍️0
Awl416 Awl416 7 years ago
That was fast
👍️0
DewDiligence DewDiligence 7 years ago
ORPN 9/30/17 cash=$4.1M (down from $5.2M at 6/30/17):

https://finance.yahoo.com/news/bioblast-pharma-reports-third-quarter-113000168.html
👍️0
DewDiligence DewDiligence 7 years ago
1:5 reverse split is effective today (eom).
👍️0
DewDiligence DewDiligence 7 years ago
ORPN implements 1:5 reverse split effective on date to be announced:

https://www.sec.gov/Archives/edgar/data/1596812/000114420417048497/v475345_6k.htm
👍️0
jcbaby jcbaby 7 years ago
you are correct this play could rise very very fast
👍️0
theprofit444 theprofit444 7 years ago
its a revised outlook lmaooooo
👍️0
jcbaby jcbaby 7 years ago
didn't you say 10 awhile back lol lets hope for anything but its current price
👍️0
theprofit444 theprofit444 7 years ago
itll be 4 dollars a share by yr end
👍️0
DewDiligence DewDiligence 7 years ago
ORPN 2Q17 PR:

https://www.sec.gov/Archives/edgar/data/1596812/000114420417040598/v472433_ex99-1.htm

6/30/17 cash was $5.2M.
👍️0
jcbaby jcbaby 7 years ago
this could rocket over a dollar in a swift blow got to be ready
👍️0
DewDiligence DewDiligence 7 years ago
Two months has elapsed since the post I'm replying to. They'd better come up with a plan soon.
👍️0
stocktrademan stocktrademan 7 years ago
ORPN buy 0.656

inverted head and shoulders bottom
bullish divergence breakout and initial pullback level
high volume on advances, lower volume on retracements indicates strong demand for the stock
pennant breakout soon
breaking out over the ichimoku cloud
moving average golden cross pattern









normal chart




log chart



👍️0
jcbaby jcbaby 8 years ago
should be an interesting day for this stock will see?
👍️0

Your Recent History

Delayed Upgrade Clock